SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-06
DOI
10.3389/fneur.2021.663911
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy
- (2020) Denise M. Kay et al. GENETICS IN MEDICINE
- Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders
- (2020) Christopher A. Tan et al. Genetic Testing and Molecular Biomarkers
- Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current Perspectives
- (2019) Tamara Dangouloff et al. Therapeutics and Clinical Risk Management
- Prevalence and properties of intragenic copy-number variation in Mendelian disease genes
- (2018) Rebecca Truty et al. GENETICS IN MEDICINE
- Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases
- (2018) Maite Calucho et al. NEUROMUSCULAR DISORDERS
- Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
- (2018) Eugenio Mercuri et al. NEUROMUSCULAR DISORDERS
- Pilot study of population-based newborn screening for spinal muscular atrophy in New York state
- (2017) Jennifer N Kraszewski et al. GENETICS IN MEDICINE
- Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria
- (2017) Keith Nykamp et al. GENETICS IN MEDICINE
- Spinal muscular atrophy: A changing phenotype beyond the clinical trials
- (2017) Eduardo F. Tizzano et al. NEUROMUSCULAR DISORDERS
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
- (2017) Richard S. Finkel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review
- (2017) Ingrid E. C. Verhaart et al. Orphanet Journal of Rare Diseases
- Next-generation sequencing in neuromuscular diseases
- (2016) Stephanie Efthymiou et al. CURRENT OPINION IN NEUROLOGY
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients
- (2015) Stephen E. Lincoln et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review
- (2015) Chia-Wei Lin et al. PEDIATRIC NEUROLOGY
- High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq
- (2015) Olga Kondrashova et al. PLoS One
- A mixed methods exploration of families’ experiences of the diagnosis of childhood spinal muscular atrophy
- (2014) Sally Lawton et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Subtle Mutation Detection of SMN1 Gene in Chinese Spinal Muscular Atrophy Patients: Implication of Molecular Diagnostic Procedure for SMN1 Gene Mutations
- (2014) Jin-Li Bai et al. Genetic Testing and Molecular Biomarkers
- Technical standards and guidelines for spinal muscular atrophy testing
- (2011) Thomas W Prior et al. GENETICS IN MEDICINE
- A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene
- (2009) Thomas W. Prior et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A rareSMN2variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy
- (2009) Myriam Vezain et al. HUMAN MUTATION
- Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy
- (2008) Mohd Shamshudin Watihayati et al. BRAIN & DEVELOPMENT
- A new splice site mutation in the SMN1 gene causes discrepant results in SMN1 deletion screening approaches
- (2007) Thomas Eggermann et al. NEUROMUSCULAR DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started